Skip to main content

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

Search

1130 result(s) found, displaying 851 to 875
  • Australian Public Assessment Report for Filgrastim (rbe)
  • Australian Public Assessment Report for Rivaroxaban
  • Australian Public Assessment Report for Cetuximab
  • Australian Public Assessment Report for Fidaxomicin
  • Australian Public Assessment Report for Linagliptin
  • Australian Public Assessment Report for Terlipressin
  • Australian Public Assessment Report for Vismodegib
  • Australian Public Assessment Report for IVIg
  • Australian Public Assessment Report for Pitavastatin
  • Australian Public Assessment Report for Rituximab
  • Australian Public Assessment Report for Aflibercept (rch)
  • Australian Public Assessment Report for C1 esterase inhibitor
  • Australian Public Assessment Report for Everolimus
  • Australian Public Assessment Report for Azacitidine
  • Australian Public Assessment Report for Lixisenatide
  • Australian Public Assessment Report for Golimumab (rmc)
  • Australian Public Assessment Report for Zonisamide
  • Australian Public Assessment Report for Micafungin (as sodium)
  • Australian Public Assessment Report for Tadalafil